Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

An Annual Review of Important Apheresis Articles in 2024 From the American Society for Apheresis Attending Physician Subcommittee

  • Wen Lu
  • , Victoria Costa
  • , Ding Wen Wu
  • , Mohamed Alsammak
  • , Grace Banez-Sese
  • , Vishesh Chhibber
  • , Gaurav K Gupta
  • , Yosef Levenbrown
  • , Yanhua Li
  • , Adela D Mattiazzi
  • , Daniel K Noland
  • , Marisa C Saint Martin
  • , Nirupama Singh
  • , Garima Siwach
  • , Laura D Stephens
  • , Gay Wehrli
  • , Yvette C Tanhehco
  • Center of Regenerative Biotherapeutics
  • New York University Langone Health
  • New York University Langone Hospital-Brooklyn
  • Lewis Katz School of Medicine at Temple University
  • Inova Fairfax Hospital Medical Campus
  • Department of Pathology and Laboratory Medicine
  • Memorial Sloan-Kettering Cancer Center
  • Sidney Kimmel Medical College at Thomas Jefferson University
  • Tufts Medical Center
  • University of Miami Miller School of Medicine
  • University of Texas Southwestern Medical Center
  • Transfusion Medicine Division
  • University of Alabama at Birmingham
  • Currently working and gaining experience as observer
  • University of California San Diego
  • Case Western Reserve University
  • Columbia University Irving Medical Center

Producción científicarevisión exhaustiva

1 Cita (Scopus)

Resumen

The American Society for Apheresis (ASFA) Attending Physician Subcommittee of the Physicians' Committee performed an annual review of articles published in 2024 related to apheresis medicine. The 10 seminal apheresis articles selected by the subcommittee members are summarized in this review. PubMed was used to identify manuscripts published in 2024 in four areas of interest: donor apheresis, therapeutic apheresis, apheresis education, and apheresis for cellular therapy. Only full length, peer-reviewed manuscripts in English with data from human subjects were included. Case reports, review articles, and meta-analyses were excluded. Articles were considered seminal if they met at least one of the following previously established criteria: novel finding(s), practice-altering outcomes, international in scope, randomized-controlled trial, relevant to current clinical practice, and/or provide evidence for category III or IV indications based on the ASFA 9th special issue of the Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach.

Idioma originalEnglish
Número de artículoe70067
Páginas (desde-hasta)e70067
PublicaciónJournal of Clinical Apheresis
Volumen40
N.º6
DOI
EstadoPublished - dic 2025

Huella

Profundice en los temas de investigación de 'An Annual Review of Important Apheresis Articles in 2024 From the American Society for Apheresis Attending Physician Subcommittee'. En conjunto forman una huella única.

Citar esto